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Abstract
Background: Prematurity accounts for about 10.6% of neo-
nates worldwide and tends to increase as does survival from 
lower gestational ages. Summary: The importance of preterm 
birth in public health stems from its link to infant and under-5 
mortality, morbidity, and its economic impact. In both the 
short and long term, preterm birth consequences are inverse-
ly related with gestational age and carry a higher risk of mortal-
ity and morbidity with neurodevelopmental, sensorial, cogni-
tive and physical health disturbances. Individuals needing life-
long support pose challenges to the responsiveness of health 
services and community systems. Public health can be decisive 
in prematurity prevention, providing data to policy-makers 
and reducing modifiable risk factors. This paper focuses on the 
long-term consequences of preterm birth and possible public 
health measures to tackle them. Key Messages: Addressing 
social determinants of health can have the highest impact on 
prematurity outcomes.
© 2019 The Author(s). Published by S. Karger AG, Basel 
on behalf of NOVA National School of Public Health
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Palavras Chave
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Resumo
Introdução: A nível mundial a prevalência da prematuri-
dade (10.6%) é crescente bem como a sobrevivência em 
idades gestacionais menores. Sumário: A importância da 
prematuridade prende-se com o contributo para a mor-
talidade infantil, para a inferior aos 5 anos e para a mor-
bilidade, com impacto económico. A curto e longo prazo, 
as consequências do nascimento pré-termo relacionam-
se inversamente com a idade gestacional, comportam 
maior risco de alterações neurológicas, sensoriais, cogni-
tivas, comportamentais e na saúde geral. A necessidade 
de apoio pode prolongar-se ao longo da vida, põe à prova 
os serviços de saúde e comunitários. A Saúde Publica 
pode ser decisiva na prevenção da prematuridade, for-
necendo aos decisores dados que permitam a redução de 
riscos modificáveis. Os autores focam-se nas consequên-
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cias a longo prazo e na abordagem da prematuridade no 
âmbito da Saúde Pública. Mensagens chave: A interven-
ção nos Determinantes Sociais de Saúde poderá ter im-
pacto decisivo no prognóstico da prematuridade.
© 2019 The Author(s). Published by S. Karger AG, Basel
on behalf of NOVA National School of Public Health
Introduction
Preterm birth (PB) is defined as birth occurring before 
37 weeks or 259 days of gestational age (GA) [1]. Prema-
turity is the main cause of an estimated one million neo-
natal deaths globally every year and a significant contrib-
uting factor to morbidities extending to adulthood [2, 3]. 
PB is sub-classified according to GA at birth into extreme-
ly preterm (< 28 weeks), very preterm (28 to < 32 weeks), 
and moderate to late preterm (32 to < 37 weeks) [4].
The risk of PB is considerable for both the higher and 
lower-income countries. However, there is a dramatic 
difference in survival of premature babies depending on 
where they are born. In high-income countries, half of the 
babies born at 24 weeks survive, while in low-income 
countries, half of those born at 32 weeks still die due to a 
lack of essential newborn (NB) care [5]. In developing 
countries, the higher PB rate is commonly associated with 
infection (malaria, HIV) and malnutrition [6]. In most 
affluent countries, the improvement of socioeconomic 
conditions, technological development, reproductive 
medicine’s success, and high quality of perinatal care con-
tributed to a heterogeneous prematurity rate but also to 
an increased survival of extreme premature infants and a 
decreasing viability threshold [7–10].
Survival to PB led to the emergence of a population of 
complex patients with different comorbidities, whose se-
verity and frequency are inversely associated with GA 
[11–17]. Some of the classic pathologies related to prema-
turity have diminished significantly in the last decades: 
hyaline membrane disease, bronchopulmonary dyspla-
sia, necrotizing enterocolitis (NEC), and retinopathy of 
prematurity (ROP). Yet, neurological morbidity, more 
specifically intraperiventricular hemorrhage (IPVH), 
presented no parallel decrease [4, 12, 14, 18, 19].
Low birth weight (LBW) is defined as the weight less 
than 2,500 g, very low birth weight (VLBW) less than 
1,500 g, and extreme low birth weight (ELBW) less than 
1,000 g [1]. LBW can occur as a result of restricted fetal 
growth or PB. LBW infants have a greater risk of poor 
outcome [20]; however, GA is a better predictor of mor-
tality and morbidity than birthweight [21–23].
Children born prematurely, especially those of extreme 
PB, have an increased risk of lifelong effects on neurode-
velopment with motor, cognitive, sensorial, physical, be-
havioral and psychopathological disturbances, compared 
with their term peers [24–26]. They require differentiated 
clinical care, early intervention, special educational pro-
grams, and social interventions, which burden families and 
health and community support systems [8, 27–31].
PB is a public health (PH) issue due to its worldwide 
prevalence, increasing survival rate, short and long-term 
morbidity, high economic burden, and because it con-
tributes to infant and under-5 mortality rates. This wide-
ranging impact has demanded attention in many high-
income countries [15, 19, 29, 32–35].
The enlarged concept of “people born preterm” can 
help healthcare providers to understand their long-last-
ing needs, provide access to health resources available 
to support postnatal infant development, and improve 
awareness of atypical clinical profiles in the long-run 
[36]. This review addresses PB as a PH matter focusing 
on its life-long consequences and strategies to tackle 
them.
Prematurity: Prevalence
According to Chawanpaiboon et al. [37], the global 
estimated preterm rate is increasing, ranging from 9.8% 
in 2000 to 10.6% in 2014. The estimated regional PB 
rates ranged from 13.4% in North Africa to 8.7% in Eu-
rope. Even though 81% of these PB occurred in Asia and 
Sub-Saharan Africa, data from some high-income and 
high-middle-income countries suggest that their PB 
rates are also increasing [37, 38]. According to data 
available from 67 countries, prevalence was higher in 
moderate or late preterm (84.7%), followed by very pre-
term (11.3%) and extremely preterm infants (4.1%) [4, 
37]. However, there are some challenges to the global 
interpretation of preterm epidemiology that can inter-
fere with PB rate estimation: diverse assessment meth-
ods of GA, prematurity definitions, data availability, 
and varying quality of vital statistics between countries 
[4, 37, 39].
The 2015 European Perinatal Health Report [38] point-
ed out that prematurity rates are heterogeneous but may be 
increasing in most European countries when comparing 
2010 with 2015, where they range between 6 and 12% of 
live births [20, 38, 40, 41] (Fig. 1). The reasons for these 
trends are not always understood. A range of factors have 
been put forward: GA assessment criteria, multiple preg-
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nancy rates, late maternal age, extreme body mass indexes, 
and socioeconomic issues, with lower-income families be-
ing at higher risk [4, 32, 34, 38, 41]. Some high- and middle-
income countries have increased numbers of provider-ini-
tiated PBs [20, 42]. Probably, higher survival has changed 
the perception of risks associated with prematurity, which 
led to an increase in non-spontaneous births [41].
It is estimated that 15–20% of all births worldwide are 
LBW. In almost all OECD countries, the proportion of 
LBW infants has increased over the past two decades, be-
ing 6.5% in 2015, representing a rise of 15% between 1990 
and 2015, mainly due to increase in PBs. [20] (Fig. 1)
In Portugal, prematurity has remained relatively stable 
in the second decade of the 21st century. According to 
Statistics Portugal (INE), the prematurity rate was of 7.8% 
in 2012 and 2013, 7.7% in 2014, 8% in 2015, and 7.8% in 
2016 [20, 43]. According to 2017 OECD indicators of 
health outcomes, Portugal registered an increase of 59% 
of LBW infants since 1990 [20].
Prematurity: Risk Factors
Prematurity can be the result of a complex combina-
tion of medical, biological, genetic, psychosocial, and en-
vironmental conditions [44]. However, in about two-
thirds of the cases the cause remains unknown, while the 
other third occurs upon medical recommendation for a 
wide-range of maternal and fetal pathologies [42, 45, 46].
Amongst multiple maternal risk factors, the following 
are emphasized: previous preterm deliveries, pregnancy 
at youngest or latest ages, short intervals between preg-
nancies, nutrition, lifestyle (physical activity, stress, work-
load), individual behavior (alcohol, tobacco, illicit drugs), 
social issues (unemployment, social support, relationship 
status, personal resources), medical maternal and preg-
nancy conditions (chronic hypertension, hypertensive 
disorders of pregnancy, diabetes mellitus, cardiac, respi-
ratory, renal, autoimmune diseases, hyperthyroidism, in-
fection), and infertility treatments [5, 6, 47].
Better understanding of the causes of PB will advance 
the development of solutions to prevent it [46].
Prematurity: Impact on PH
Mortality
Globally, circa 44% of deaths in children under under-
five occurred in the neonatal period, PB being the com-
monest cause of neonatal death [20, 48, 49]. Approxi-
0
Note:
First-period data not from 2010: Cyprus 2007
Second-period data not from 2015: Bulgaria 2014, Poland 2014,
Sweden 2014, Switzerland 2014
Switzerland
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Fig. 1. Percentage of preterm live births in Europe in 2010 and 
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mately 1 million children die each year due to complica-
tions of PB [2, 20].
Each additional week of gestation results in an in-
creased survival rate [29, 49]. The GA survival threshold, 
defined as long-term survival above 50% [50], has been 
decreasing. In some high-income countries, it is as low as 
23 weeks [49]. Survival without major morbidity in 
VLBW infants is increasing, ranging from 53 to 71% in 
different studies [49, 51, 52].
The overall in-hospital survival differs among neona-
tal networks from 78 to 93% – range at 24 weeks 35–84% 
and at 29 weeks 92–98% [53]. Stoll et al. [12] described 
survival at discharge of 6% at 22 weeks and 92% at 28 
weeks. In a study from Canada, Johnston et al. [138] esti-
mated similar survival rates amongst live births at age 2 
and 10, circa 56.0% survival at < 28 weeks, 92% at 28–32 
weeks, and 98% at 33–36 weeks. Cheong et al. [54] de-
scribe a 73% survival at 8 years of a corrected age in a co-
hort of extreme preterm [11, 12].
In a Swedish population-based study, Crump et al. 
[25] described that, among individuals born in the 1973–
1979 period, low GA at birth was independently associ-
ated with increased mortality in young adulthood .
The survival threshold in Portugal is 25 weeks. Ac-
cording to the Portuguese Very Low Birth Weight Infant 
Registry, in 2013, the overall survival rate was 89%. Per 
GA intervals, survival rates were 95.3% for 28 and 31 
weeks, 77.6% for 25 to 27 weeks, and 42.1 and 16.7% for 
24 and 23 weeks, respectively [55].
Reducing mortality associated with complications of 
prematurity will be crucial to reduce worldwide under-
five mortality.
Morbidity
Improved survival of preterm infants leads to short- and 
long-term higher risk of neurological, cognitive, sensorial, 
respiratory, digestive, renal, cardiovascular, metabolic, im-
mune, and psychosocial disturbances [4, 22, 25, 26, 36, 56, 
57]. We will focus preferentially on those morbidities that 
are life-long in extreme and very preterm infants.
Neurodevelopmental impairment (NDI) is displayed 
in 5% of all PBs [58]. Survival without NDI at 2 years of 
age has become a common benchmark for success. While 
most neurodevelopmental disabilities are not major defi-
cits, they should be clinically considered [59]. Some of 
these morbidities are not evident at discharge or even at 
2 years of age [59]. Therefore, long-term follow-up is 
needed to properly evaluate the consequences of PB.
In the early years of life, preterm infants often contin-
ue to experience physical health problems that may re-
quire frequent medical visits and re-hospitalization. This 
may limit their participation in regular childhood activi-
ties, which may in turn affect their social skills.
Neurological morbidity is responsible for a high risk 
of cognitive, motor, and sensory impairment. Periven-
tricular leukomalacia (PVL), IPVH, and post-hemor-
rhagic hydrocephaly are the main determinants of neuro-
developmental outcomes [17, 22, 60–65]. Motor deficits 
in children born preterm are generally identified earlier, 
but some of them are transitory (poor head control, hy-
potonia, or hypertonia) disappearing near 12 months 
[66]. However, some psychomotor disturbances will ini-
tially be clinically silent [67]. Different studies among 
VLBW/ELBW children at school-age [68] and ELBW 
children at ages 11–13 years [61] found a higher likeli-
hood for developmental coordination disorder and an in-
creased risk for long-term motor impairment. Preterm 
infants surviving into adulthood after neonatal IPVH or 
PVL continue to be at very high risk of poor neurological 
outcomes [69].
Cerebral palsy (CP) is one of the major neurological 
complications of premature birth. Survivors of extreme 
prematurity have rates of CP in childhood 70–80 times 
higher than those in term infants [17, 70–73]. Studies of 
time trends in the prevalence of CP have shown different 
results [37, 70, 73–75]. For children born in Portugal in 
2001–2007, the prevalence of CP at 5 years of age was esti-
mated to be 4.6-fold higher in children born at 32–36 weeks’ 
gestation, 45.1-fold higher in those born at 28–31 weeks, 
and 70.1-fold higher in children born at < 28 weeks’ gesta-
tion, compared with children born at term (Table 1) [76].
Diagnosis of high CP risk can be established by 6 
months of corrected age with a combination of medical 
history, standardized motor assessment and neuroimag-
ing [15, 17]. Most studies of VLBW infants show cogni-
tive deficits (lower intelligence quotient, intellectual, 
learning disabilities, and executive dysfunction), academ-
ic underachievement and grade failures [77]. Early refer-
ral to CP-specific early intervention is critical to improve 
functional outcomes.
ROP is the main cause of visual deficit in preterm 
infants [78]. They have an increased risk of long-term 
visual disorders due to the combination of development 
interruption of the visual system due to preterm deliv-
ery and/or neurological complications, oxygen toxicity, 
infection, glycemia disorders, undernutrition, and ge-
netic factors [15, 77–82]. ROP is a progressive disease 
characterized by fibrovascular proliferation at the pe-
riphery of the retina with risk of retinal detachment. It 
has a multifactorial etiology, prematurity being its main 
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determinant [83–85]. It is recorded in about 2–11% of 
VLBW infants [77, 83]. The rate of blindness and/or 
severe visual impairment is inversely related to GA (1–
2% at 26–27 weeks and 4–8% at ≤25 weeks) [77]. Myo-
pia and hypermetropia arise in at least a quarter of chil-
dren born < 28 weeks [86]. The need to prescribe glass-
es is also related to GA, with 24% at the age of 6 < 26 
weeks’ GA wearing glasses versus 4% of term controls. 
This difference continues into adolescence and adult-
hood [87, 88]. A high rate (4–5%) of late retinal detach-
ment in ELBW infants during their late teens has been 
observed [79, 81, 88].
Hearing impairment has a detrimental effect on the 
development of language, learning, communication 
skills, quality of life, and on economic independence in 
adult life [89, 90]. VLBW infants have central auditory 
processing difficulties, including in discerning simple 
speech sounds and worse auditory recognition than their 
full-term counterparts [91]; a prevalence of 0.1–0.2% has 
been reported [92], and may be 10–50% higher in VLBW 
infants [77, 87, 92]. Hypoxia, hyperbilirubinemia, infec-
tions, ototoxic therapeutics, and exposure to noise can 
irreversibly damage the cochlear, vestibular organs, the 
auditory nerve, and cortex [92]. Hearing loss may be pro-
gressive and diagnosed late in life (2–4 years of age), re-
quiring long-term surveillance to timely introduce hear-
ing aid wear [92, 93].
Cognitive deficit is the most prevalent disability in the 
population of preterm children. Very preterm survivors 
have high rates of cognitive dysfunction and emotional 
troubles at school age that affect academic functioning 
and progress [94]. Case-control studies have shown that 
very preterm children have significantly lower intelli-
gence quotient scores than term peers. The most signifi-
cant neonatal risk factors are severe IVH, PVL, neonatal 
seizures, NEC, and long-term ventilation [95]. Cognitive 
dysfunctions seem influenced by environmental factors 
such as parental socioeconomic status and education [95, 
96]. Follow-up revealed that many of the difficulties per-
sisted into adolescence and early adulthood [94]. Long-
term monitoring will be important to identify later cogni-
tive impairment and educational needs.
Language disorders have been reported in children born 
preterm in its different domains (receptive, expressive, ar-
ticulation). Several biologic and environmental factors in-
fluence language outcomes. Regular exposure to speech is 
essential to auditory cortex and speech development, social 
interaction and later school achievement [97, 98].
Behavioral and psychopathological disturbances are 
more prevalent in individuals born preterm and are also 
inversely related to the GA. These disturbances often 
coexist with motor, language, and cognitive problems 
[51, 99–102].
The risk of behavioral problems, such as attention def-
icit hyperactivity disorder, is increased by 2.6–4 times in 
very preterm infants in early childhood. They also often 
present more school problems and anxious and depres-
sive symptoms, risk of hospitalization for mental disor-
ders and borderline behavioral problems while transi-
tioning to adolescence. However, they were less prone to 
delinquency and risk-seeking behaviors than control 
young adults [16, 99, 103]. Lower self-esteem, lower em-
ployability, and lower income have also been reported as 
frequently found in adulthood [104, 105]. Nevertheless, 
the self-perception of the quality of life seems to be posi-
tive [16]. The relevance of the screening for behavioral 
and psychiatric changes and timely intervention in this 
area is emphasized.
Table 1. Cerebral palsy risk at 5 years of age associated with gestational age at birth
<28 weeks 28–31 weeks 32–36 weeks >36 weeks
Live births 1.937 4.803 46.774 711.525
Registered cases 109 174 174 571
Incidence rate 56.27 36.23 3.72 0.80
Incidence rate, 95% CI 46.86–6.44 31.30–41.89 3.21–4.31 0.74–0.87
CP risk <28 vs. >36 weeks Relative risk 70.12; 95% CI 57.41–85.64
CP risk 28–31 vs. >36 weeks Relative risk 45.14; 95% CI 38.19–53.57
CP risk 32–36 vs. >36 weeks Relative risk 4.64; 95% CI 3.91–5.49
CP, cerebral palsy; CI, confidence interval. Children born in Portugal between 2001 and 2007 (n = 1,098). The 
lower risk group (<36 weeks of gestational age) is considered the reference group to cerebral palsy relative risk 
calculation at 5 years of age. Data from October 31, 2016. Reproduced with permission from reference [76]. 
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Bronchopulmonary dysplasia is defined by oxygen de-
pendence after 28 days of life or 36 weeks of postmen-
strual age [106]. Arrested vascularization and augmented 
vasoreactivity may lead to the development of pulmonary 
hypertension in the weeks and months after PB [107–
109]. It has a prevalence of about 40% in infants born at 
GA < 28 weeks [110]. It is associated with invasive ventila-
tion, oxygen toxicity, pre- and postnatal infection, nutri-
tional deficit, and possible genetic susceptibility [106, 
111]. In the long term, respiratory impairment, particu-
larly if exposed to noxious substances, has been observed 
resulting in changes in the respiratory function, bronchi-
al hyperreactivity, sometimes with an atypical clinical 
profile (asthma-like), reduced tolerance to exercise, in-
creased risk of respiratory infections needing hospital ad-
mission, pulmonary hypertension, some needing ventila-
tion support at home [19, 30, 106, 112].
Intestinal failure is a reduction in the functional gut 
mass below a critical threshold necessary to maintain 
growth, hydration, and electrolyte balance [113]. The 
leading cause of intestinal failure in neonates is anatomic 
short bowel syndrome, and NEC inflammation and ne-
crosis of the intestinal wall are its predominant cause in 
VLBW infants [102, 113–115]. The long-term need for 
parenteral nutrition is associated with cholestasis, hepat-
ic insufficiency, long-term central catheters, and higher 
risk of infections [15, 116]. Besides a high lethality (15–
60%), advances in parenteral nutrition, infection preven-
tion, surgery techniques, and transplantation have im-
proved prognosis [117].
High-risk renal long-term outcomes in preterm NB 
appear to be associated with early acute renal injury [115, 
118]. PB occurs in the active phase of nephrogenesis, re-
sulting in fewer nephrons. Nephrotoxic medications can 
potentiate kidney function impairment, increasing the 
risk of chronic kidney disease [119, 120]. Acute neonatal 
kidney injury risk is around 12–39%, even though its con-
nection with chronic kidney disease is not yet clear [118]. 
These patients should be monitored regularly for long-
term kidney damage [121, 122].
Cardiometabolic syndrome (CMS) is a combination of 
metabolic dysfunctions characterized by resistance to in-
sulin, diminished tolerance to glucose, dyslipidemia, hy-
pertension, and intra-abdominal adiposity [123]. Barker 
et al. [124, 125] suggested, in the late 1990s, the inverse 
correlation between LBW, risk of cardiovascular disease, 
and type 2 diabetes in adult life. Variations in fetal and 
postnatal nutrition could be linked to the modification of 
genetic expression, resulting in the programming of long-
term chronic disease [126, 127]. In the long run, CMS is 
also reinforced by lifestyle: less physical exercise and in-
adequate diet. Adequate interventions may reduce the 
impact of this pathology [126, 128].
Venous thromboembolism (VTE) is considered to be 
a complex disorder influenced by several genetic and en-
vironmental factors and affects circa 1 in 1,000 individu-
als per year [129]. Zöller et al. [130], found that low GA 
at birth was associated with an increased risk of VTE in 
infancy, early childhood, and young adulthood, suggest-
ing that PB could be an important risk factor for later 
VTE [129, 131].
Disorders of the immune system can account for the 
high susceptibility of preterm neonates to infection [132–
135]. PB interrupts the fetal acquisition of passive immu-
nity and favors a different, precocious dermal and gastro-
intestinal microbiome acquisition, different from that of 
term neonates [132–137]. Better understanding of the 
characteristics of the immune system in preterm infants 
is challenging [135].
Economic Impact
The economic impact of prematurity is assumed to be 
high, including not only the immediate neonatal inten-
sive care costs but also ongoing long-term complex 
healthcare needs. The complexity of the clinical situation 
of some survivors, particularly those of earlier GA, deter-
mines the need for concerted multidisciplinary action 
and a consequent response by health, social, community, 
rehabilitation and special education departments.
The US Institute of Medicine (IOM) published in 2007 
the report “Preterm Birth, Causes, Consequences and 
Prevention”, in which the estimated economic impact 
(medical, educational and lost productivity combined) of 
PB in the USA in 2005 accounted for USD 26.2 billion or 
USD 51,600 for each child born prematurely [44]. The 
average first-year medical costs, including both inpatient 
and outpatient care, were about 10 times greater for pre-
term (USD 32,325) than for term infants (USD 3,325). 
The average length of stay was nine times longer for a 
preterm NB (13 days), compared with a baby born at term 
(1.5 days) [44].
Johnston et al. [138] concluded in 2014, that PB re-
sulted in significant morbidity, mortality, and high costs 
for health services in Canada. Although the highest ex-
penditure was concentrated in the neonatal period, the 
costs and resources use continued throughout childhood. 
Whilst the largest group was composed of moderately 
premature infants, it was the group of extreme prematu-
rity that cost the most [138].
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A systematic review by Petrou et al. [139] on the long-
term costs of prematurity after hospital discharge con-
cluded that PB and LBW result in substantial costs for 
health systems, special education, social services, family 
and caregivers, and society in general.
Blencowe et al. [56] estimated that in 2010 all PBs 
worldwide would have been responsible for 77 million 
disability-adjusted life years, accounting for 3.1% of the 
global total, of which 3 million would be years lived with 
disability.
The evaluation of direct healthcare costs associated 
with prematurity encompasses both hospital admissions 
(initial and subsequent) and those related to outpatients 
(therapies, clinical, educational, and social support). Out-
of-pocket expenses were substantial and significantly 
higher for very preterm and VLBW infants [5]. The indi-
rect costs (loss of productivity of the caregivers, emotion-
al stress, and repercussion on the families and quality of 
life) although more difficult to assess, should be consid-
ered to allow for a more comprehensive quantification of 
the burden of individuals surviving prematurity. Several 
authors have drawn attention to the high social costs from 
a family perspective [28, 140, 141].
MPT Infants 
Babies born MPT account for more than 80% of all PB, 
of which the majority remained without disabilities in the 
long-term; however, when compared to full-term infants, 
they have increased mortality and experience higher mor-
bidity, which had been underestimated in the past [138].
Johnston et al. [138] describe a survival rate of 93% at 
age 2 and 10 in moderate, and 98% in late preterm infants; 
the majority of children remained disability-free at age 10.
MPT however, have higher rates of mortality and short-
term morbidity. Worse neurodevelopmental and school 
performance outcomes, increased risk of CP and costs per 
infant than their term peers, have been pointed out [138]. 
Other common neonatal morbidities in these infants in-
clude hypothermia (known to be associated with worse 
outcomes), hypoglycemia (increasing likelihood of long-
term neurological sequelae), difficulties in establishing oral 
feeding (slow feeding, choking episodes, desaturation 
events, bradycardia, and apnea), jaundice, and short and 
long-term respiratory compromise (respiratory distress 
syndrome, transient tachypnoea and pneumonia, in-
creased risk of bronchiolitis and wheezing) [142–144].
Long-term health and neurodevelopmental problems, 
as well as educational difficulties are known to occur [25]. 
Although very and extreme preterm infants were associ-
ated with the highest expenditures, MPT healthcare needs 
impact significantly upon pediatric healthcare, due to 
their larger population size [138, 143].
Prematurity: Prevention
PH can be decisive in reducing modifiable risk factors 
of prematurity, improving perinatal care, and supporting 
postnatal infant development. Whilst the risk of adverse 
outcome is highest among very preterm [18, 96], MPT 
represent a large population for whom PH policy can be 
most effective [103, 143–145].
The prevention of prematurity requires a multifaceted 
approach aiming to globally improve women’s health, 
starting before pregnancy but also focusing on precon-
ception and gestational periods [44, 146]. Intervention 
on social determinants of health can reduce some risk 
factors, influencing PB rates and outcomes [147]. PH in-
tervention can be crucial in controlling adverse social 
conditions, namely poverty, discrimination, violence, 
low education, and intervention for behavioral factors 
(alcohol, tobacco, or illicit drug use); regulations to pro-
tect women from workload or exposure to potential 
harmful pollutants, improving adequate spacing (> 24 
months) and preventing teenage or unintended preg-
nancies [44, 147].
In the preconception period, equality in access to pri-
mary, preventive, and obstetric risk care is highlighted. 
Regimentation of assisted reproductive therapies (ART), 
aimed to reduce the risk of higher-order multiples, focused 
on reducing the number of embryos for transfer (elective 
single embryo transfer policy) and eventually limiting can-
didate’s age to ART, are relevant issues [148, 149]. During 
gestation, the relevance of early identification of women at 
risk for preterm delivery has been stressed as it leads to ef-
fective preventive treatments, control of chronic diseases, 
optimization of body mass index, eradication of non-med-
ically indicated deliveries before 39 weeks, and effective 
management of preterm labor [5, 44].
In assessing adequate preterm delivery, occurring in a 
high-level quality care, neonatal resuscitation, compre-
hensive neonatal intensive care, special infant feeding 
support, and management of neonatal complications are 
important issues.
It is essential to put in place adequate policies to inte-
grate premature babies within interventional programs to 
track long-term disabling outcomes and to support post-
natal infant development [150].
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The need to research prematurity causes and their in-
terrelationship, to search for newer therapeutics and pre-
ventive approaches of PB is key. PH can provide popula-
tion-based surveillance systems to monitor trends in pre-
maturity, prevention efforts, risk factor evolution, and 
outcomes in PB [151–153].
Conclusion
The increasing survival at progressively lower GA 
with a higher risk of morbidity, draws attention to the 
high number of people surviving from prematurity in 
terms of PH [28, 41, 154]. Dissemination of knowledge 
about the causes and prevention of PB, the extent of 
morbidity and mortality associated to prematurity, and 
their impact on families and support structures must be 
relevant to policy makers. Addressing social determi-
nants of health can reduce PB rates and improve out-
comes. This knowledge and consequent multifaceted 
action may contribute to gains in terms of health eco-
nomics and optimization of the human potential of in-
dividuals born preterm and their families. The burden 
of PB highlights the crucial importance of prematurity 
prevention – it must be a priority issue in health policy 
makers’ agenda.
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